Cystic fibrosis in adults;Mukoviszidose im erwachsenenalter

Internist

Volumn 51, Issue SUPPL. 1, 2010, Pages 277-288

  Pletz, M W ^a   Sauer Heilborn, A ^a   Kohnlein T ^a   Seidler, U ^a   Lamprecht, G ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Aspergillosis; Cystic fibrosis; Diabetes mellitus; Haemoptysis; Pancreatic insufficiency

Indexed keywords

ADRENALIN; AZITHROMYCIN; CIPROFLOXACIN; IBUPROFEN; LEVOFLOXACIN; MEROPENEM; TOBRAMYCIN; TRANSMEMBRANE CONDUCTANCE REGULATOR; CARRIER PROTEIN; GOPC PROTEIN, HUMAN; MEMBRANE PROTEIN;

ADULT; AUTOSOMAL RECESSIVE DISORDER; BACTERIAL COLONIZATION; BILIARY CIRRHOSIS; BRONCHIECTASIS; CYSTIC FIBROSIS; DEATH; DIABETES MELLITUS; DIGESTIVE SYSTEM; GENE MUTATION; HEMOPTYSIS; HUMAN; ILEUS; LUNG ASPERGILLOSIS; LUNG TRANSPLANTATION; MALABSORPTION; MUCOCILIARY CLEARANCE; PANCREAS INSUFFICIENCY; PANCREATITIS; PATHOLOGY; PNEUMONIA; PNEUMOTHORAX; PSEUDOMONAS AERUGINOSA; RESPIRATORY SYSTEM; REVIEW; SECRETION; ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; BACTERIAL PNEUMONIA; CHILD; CHROMOSOME ABERRATION; DIFFERENTIAL DIAGNOSIS; GENETICS; LUNG DISEASE; NEWBORN; NUCLEOTIDE SEQUENCE; PROGNOSIS; PSEUDOMONAS INFECTION; RECESSIVE GENE;

ADULT; ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; BRONCHIECTASIS; CARRIER PROTEINS; CHILD; CHROMOSOME ABERRATIONS; CYSTIC FIBROSIS; DIAGNOSIS, DIFFERENTIAL; DNA MUTATIONAL ANALYSIS; GENES, RECESSIVE; HEMOPTYSIS; HUMANS; INFANT, NEWBORN; LUNG DISEASES; MEMBRANE PROTEINS; PNEUMONIA, BACTERIAL; PROGNOSIS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 77953654385     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00108-009-2527-3     Document Type: Review

References (16)

1. Balfour-Lynn IM, Welch K (2009) Inhaled corticosteroids for cystic fibrosis. Cochrane Database Syst Rev 2: CD001915
2. Ballmann M, Smaczny C (2008) Diagnostik inclusive Screening. In: Ballmann M, Smaczny C (Hrsg) CF-Manual, 2nd edn. Unimed, Bremen, S 18-21
3. Boyle MP (2003) Nonclassic cystic fibrosis and CFTR-related diseases. Curr Opin Pulm Med 9:498-503
4. Boyle MP (2007) Adult cystic fibrosis. JAMA 298:1787-1793
5. Cystic Fibrosis Foundation (1994) Microbiology and infectious disease in cystic fibrosis. Cystic Fibrosis Foundation, Bethesda, p 1-26
6. Doring G, Hoiby N, Consensus Study Group (2004) Early intervention and prevention of lung disease in cystic fibrosis: A European consensus. J Cyst Fibros 3:67-91
7. Flume PA, O'Sullivan BP, Robinson KA et al. (2007) Cystic fibrosis pulmonary guidelines: Chronic medications for maintenance of lung health. Am J Respir Crit Care Med 176 (10):957-969
8. Fuehner T, Pletz M, Welte T (2006) Exazerbation bei Bronchiektasen und zystischer Fibrose. Pneumologe 3:37-45
9. Gottlieb J, Ballmann M, Mallinckrodt C von et al. (2009) Lung transplantation in cystic fibrosis - a position paper. Pneumologie 63:451-460
10. Greenberger PA (2002) Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 110:685-692
11. Heijerman H, Westerman E, Conway S et al. (2009) Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: A European consensus. J Cyst Fibros 8:295-315
12. Kohnlein T, Welte T (2009) Mukoviszidose: Ein kurzer Oberblickfiir die pneumologische Praxis. Pneumologe 6:41-50
13. Lai HJ (2006) Classification of nutritional status in cystic fibrosis. Curr Opin Pulm Med 12:422-427
14. Teich N, Mossner J (2008) Hereditary chronic pancreatitis. Best Pract Res Clin Gastroenterol 22:115-130
15. Thornton J, Rangaraj S (2009) Disease modifying anti-rheumatic drugs in people with cystic fibrosisrelated arthritis. Cochrane Database Syst Rev 1: CD007336
16. Wilschanski M, Durie PR (2007) Patterns of Gl disease in adulthood associated with mutations in the CFTR gene. Gut 56:1153-1163